RAPT Q2 2023 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RAPTRAPT Therapeutics, Inc.

$959M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$28M

Net Income

-$25M

EPS (Diluted)

$-5.28

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$221M

Total Liabilities

$21M

Stockholders' Equity

$200M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$886,000	-100.0%
Gross Profit	$0	$886,000	-100.0%
Operating Income	-$28M	-$19M	-50.0%
Net Income	-$25M	-$19M	-31.8%